These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37371795)

  • 21. Does allergen immunotherapy for allergic rhinitis prevent asthma?
    Arshad SH
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):286-291. PubMed ID: 35500864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
    Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J
    Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
    Feng M; Zeng X; Li J
    J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy.
    Justicia JL; Padró C; Roger A; Moreno F; Rial MJ; Parra A; Valero A; Malet A; Teniente A; Boronat A; Torán-Barona C
    World Allergy Organ J; 2021 Jun; 14(6):100545. PubMed ID: 34178239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
    Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
    Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-World Safety and Effectiveness Evidence of a Microcrystalline Tyrosine-Associated Mite Allergoid in Children and Adolescents with Allergic Rhinitis.
    Anna SC; Zulay M AS; Ignacio GN; Sofia L; Juan A MT; Maria D M; Ramón N; Mercedes R; Anna B; Carla TB; José L J
    Allergol Immunopathol (Madr); 2021; 49(4):98-108. PubMed ID: 34224224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients.
    Qi S; Chen H; Huang N; Li W; Liu G; Wang Y; Hu L; Wang X; Zhang W; Zhu R
    Int Arch Allergy Immunol; 2016; 171(3-4):234-240. PubMed ID: 28049194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary IgG4 Levels Contribute to Assessing the Efficacy of
    Liu J; Hu M; Tao X; He J; Wang J; Song Z; Wu L; Tang L; Chen Z; Xu X
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study.
    Fritszching B; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Contoli M
    Front Pediatr; 2023; 11():1136942. PubMed ID: 37063677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen immunotherapy and asthma.
    Tosca MA; Olcese R; Licari A; Ciprandi G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():46-48. PubMed ID: 32017211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
    Russkamp D; Aguilar-Pimentel A; Alessandrini F; Gailus-Durner V; Fuchs H; Ohnmacht C; Chaker A; de Angelis MH; Ollert M; Schmidt-Weber CB; Blank S
    Allergy; 2019 Aug; 74(8):1549-1560. PubMed ID: 30829405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
    Padró C; Gutiérrez D; Moreno F; Parra A; Rial MJ; Lleonart R; Torán-Barona C; Justicia JL; Roger A
    Immun Inflamm Dis; 2022 May; 10(5):e585. PubMed ID: 35478444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and effectiveness of a microcrystalline tyrosine-associated mite extract immunotherapy for allergic rhinitis.
    Sala-Cunill A; Pérez-Formoso JL; Torán-Barona C; Almeida-Sánchez ZM; Álvarez-Fernández JA; García-Núñez I; Linana-Santafé JJ; Martínez-Tadeo JA; Boronat-Barado A; Justicia JL
    Immunotherapy; 2020 Sep; 12(13):1007-1019. PubMed ID: 32811270
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.
    Bożek A; Kołodziejczyk K; Kozłowska R; Canonica GW
    Clin Transl Allergy; 2017; 7():43. PubMed ID: 29214012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
    Liu Y; Xing Z; Wang J; Geng C
    Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis.
    Ferrando M; Bagnasco D; Passalacqua G; Varricchi G; Canonica GW
    Expert Opin Biol Ther; 2016 Nov; 16(11):1435-1441. PubMed ID: 27620194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved pulmonary function test (PFT) after 1 one year of Sublingual Immunotherapy (SLIT) in unison with pharmacotherapy in mild allergic asthmatics.
    Beigh AH; Rasool R; Kawoosa F; Manzoor S; Rashid R; Andrabi KI; Shah ZA; Qureshi T
    Immunol Lett; 2021 Feb; 230():36-41. PubMed ID: 33340589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.